Facet browsing currently unavailable
Page 1 of 633 results
Sort by: relevance publication year
Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Early-Phase Insulin Secretion in Drug-Naïve Patients with Type 2 Diabetes JOURNAL ARTICLE published September 2015 in Drugs in R&D |
C60 Fullerene as Synergistic Agent in Tumor-Inhibitory Doxorubicin Treatment JOURNAL ARTICLE published December 2014 in Drugs in R&D |
Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin’s Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study JOURNAL ARTICLE published June 2023 in Drugs in R&D |
Artist® Tablets (Carvedilol) for Hypertensive Patients in Japan JOURNAL ARTICLE published June 2011 in Drugs in R&D |
Long-Term Maintenance of Golimumab Effectiveness for Injection Spacing in Rheumatoid Arthritis Patients with Low Disease Activity Who Previously Received Other TNF Inhibitors: Minimum 2-year Data From an Observational Study JOURNAL ARTICLE published September 2021 in Drugs in R&D |
Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change JOURNAL ARTICLE published March 2019 in Drugs in R&D |
Bioequivalence of Eslicarbazepine Acetate from Two Different Sources of its Active Product Ingredient in Healthy Subjects JOURNAL ARTICLE published June 2013 in Drugs in R&D |
Association between Acid-Suppressive Drugs and Clinical Outcomes in Patients with Nonvalvular Atrial Fibrillation JOURNAL ARTICLE published September 2022 in Drugs in R&D Research funded by Japan Society for the Promotion of Science (JP21H03176) |
Correction: Association between Acid-Suppressive Drugs and Clinical Outcomes in Patients with Nonvalvular Atrial Fibrillation JOURNAL ARTICLE published September 2022 in Drugs in R&D |
Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions JOURNAL ARTICLE published December 2022 in Drugs in R&D Research funded by Science and Technology Key Program of Hunan Province Grants (2016SK2066) | Hunan Province Chinese Medicine Research Program Grants (201940) | Science and Technology Key Program of Hunan Provincial Health Committee (20201904) | Natural Science Foundation of Hunan Province (2021JJ30753) | Changsha Central Hospital Affiliated to University of South China Foundation of key Program (YNKY202205) | Hunan Province Foundation of High-level Health Talent (225 Program) |
Switching α-Glucosidase Inhibitors to Miglitol Reduced Glucose Fluctuations and Circulating Cardiovascular Disease Risk Factors in Type 2 Diabetic Japanese Patients JOURNAL ARTICLE published September 2014 in Drugs in R&D |
Budget Impact Analysis of Warfarin Reversal Therapies Among Hip Fracture Patients in Finland JOURNAL ARTICLE published March 2015 in Drugs in R&D |
Efficacy and Safety of a Lercanidipine/Enalapril Fixed-Dose Combination in Hypertensive Patients in Portugal JOURNAL ARTICLE published June 2014 in Drugs in R&D |
Concordance of Vancomycin Population-Predicted Pharmacokinetics with Patient-Specific Pharmacokinetics in Adult Hospitalized Patients: A Case Series JOURNAL ARTICLE published June 2020 in Drugs in R&D |
Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects JOURNAL ARTICLE published September 2021 in Drugs in R&D |
Real-World Experience of Carglumic Acid for Methylmalonic and Propionic Acidurias: An Interim Analysis of the Multicentre Observational PROTECT Study JOURNAL ARTICLE published March 2024 in Drugs in R&D |
Acknowledgement to Referees JOURNAL ARTICLE published December 2014 in Drugs in R&D |
Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Poor Response to Existing Alpha-1 Blockers: The SPLASH Study JOURNAL ARTICLE published March 2019 in Drugs in R&D |
Dipeptidyl Peptidase-4 Inhibitor (Vildagliptin) Improves Glycemic Control After Meal Tolerance Test by Suppressing Glucagon Release JOURNAL ARTICLE published December 2014 in Drugs in R&D |
Identification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System Data JOURNAL ARTICLE published March 2017 in Drugs in R&D |